Cite
HARVARD Citation
Riecken, L. et al. (n.d.). Inhibition of RAS Activation Due to a Homozygous Ezrin Variant in Patients with Profound Intellectual Disability. Human mutation. 36 (2), pp. 270-278. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Riecken, L. et al. (n.d.). Inhibition of RAS Activation Due to a Homozygous Ezrin Variant in Patients with Profound Intellectual Disability. Human mutation. 36 (2), pp. 270-278. [Online].